Sustained elevations in NEFA induce cyclooxygenase-2 activity and potentiate THP-1 macrophage foam cell formation

Atherosclerosis

Volumn 192, Issue 1, 2007, Pages 49-55

  Lloyd, Eric E ^a   Gaubatz, John W ^a   Burns, Alan R ^a   Pownall, Henry J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adipogenesis; Atherosclerosis; COX 2; Inflammation; NEFA

Indexed keywords

CARBON 11; CYCLOOXYGENASE 2; FATTY ACID; FATTY ACID BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; OLEIC ACID; TRIACYLGLYCEROL;

ADIPOCYTE; ARTICLE; ATHEROSCLEROSIS; CELL LABELING; CONTROLLED STUDY; ENZYME ACTIVITY; FOAM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; LIPOGENESIS; MACROPHAGE; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ADIPOCYTES; ALBUMINS; ANTIGENS, CD36; CELL LINE; CYCLOOXYGENASE 2; FATTY ACIDS, NONESTERIFIED; FOAM CELLS; GENE EXPRESSION PROFILING; HUMANS; LIPID METABOLISM; MACROPHAGES; MOLECULAR SEQUENCE DATA; OLEIC ACID;

EID: 34247156222     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.06.014     Document Type: Article

References (29)

1. McGarry J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002) 7-18
2. Lemieux I. Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk?. Arterioscler Thromb Vasc Biol 24 (2004) 795-797
3. Vilbergsson S., Sigurdsson G., Sigvaldason H., et al. Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavik Study 17-year follow up. J Intern Med 244 (1998) 309-316
4. Lowry O.H., Rosebrough N.J., Farr A.L., et al. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265-275
5. Slayback J.R., Cheung L.W., and Geyer R.P. Quantitative extraction of microgram amounts of lipid from cultured human cells. Anal Biochem 83 (1977) 372-384
6. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226 (1957) 497-509
7. White T., Bursten S., Federighi D., et al. High-resolution separation and quantification of neutral lipid and phospholipid species in mammalian cells and sera by multi-one-dimensional thin-layer chromatography. Anal Biochem 258 (1998) 109-117
8. Shepherd J., Bedford D.K., and Morgan H.G. Radioiodination of human low density lipoprotein: a comparison of four methods. Clin Chim Acta 66 (1976) 97-109
9. Via D.P., Dresel H.A., and Gotto Jr. A.M. Isolation and assay of the Ac-LDL receptor. Methods Enzymol 129 (1986) 216-226
10. Roden M., Price T.B., Perseghin G., et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97 (1996) 2859-2865
11. Otto J.C., DeWitt D.L., and Smith W.L. N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J Biol Chem 268 (1993) 18234-18242
12. Health, United States, 2004 with Chartbook on Trends in the Health of Americans, United States. U.S. Department of Health and Human Services, CDC, NCHS; 2004.
13. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998;158:1855-1867.
14. Randle P.J., Garland P.B., Hales C.N., et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1 (1963) 785-789
15. Coe N.R., Simpson M.A., and Bernlohr D.A. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res 40 (1999) 967-972
16. Makowski L., Boord J.B., Maeda K., et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7 (2001) 699-705
17. Fu Y., Luo N., and Lopes-Virella M.F. Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J Lipid Res 41 (2000) 2017-2023
18. Miyaoka K., Kuwasako T., Hirano K., Nozaki S., Yamashita S., and Matsuzawa Y. CD36 deficiency associated with insulin resistance. Lancet 357 (2001) 686-687
19. Febbraio M., Abumrad N.A., Hajjar D.P., et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274 (1999) 19055-19062
20. Ibrahimi A., Bonen A., Blinn W.D., et al. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 274 (1999) 26761-26766
21. Vallve J.C., Uliaque K., Girona J., et al. Unsaturated fatty acids and their oxidation products stimulate CD36 gene expression in human macrophages. Atherosclerosis 164 (2002) 45-56
22. Patrignani P. Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease. Thromb Res 110 (2003) 281-286
23. Ohnaka K., Numaguchi K., Yamakawa T., and Inagami T. Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells. Hypertension 35 (2000) 68-75
24. Cipollone F., Prontera C., Pini B., et al. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation 104 (2001) 921-927
25. Cipollone F., Fazia M., Iezzi A., et al. Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans. Circulation 107 (2003) 1479-1485
26. Patel R.N., Attur M.G., Dave M.N., et al. A novel mechanism of action of chemically modified tetracyclines: inhibition of COX-2-mediated prostaglandin E2 production. J Immunol 163 (1999) 3459-3467
27. Lee J.Y., Sohn K.H., Rhee S.H., et al. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4. J Biol Chem 276 (2001) 16683-16689
28. Swislocki A.L., Chen Y.D., Golay A., et al. Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia 30 (1987) 622-626
29. Chung B.H., Tallis G.A., Cho B.H., et al. Lipolysis-induced partitioning of free fatty acids to lipoproteins: effect on the biological properties of free fatty acids. J Lipid Res 36 (1995) 1956-1970